The crypto market shows mixed performance, with RWA sector up nearly 2%, while the NFT sector drops over 4%.
According to Odaily, based on SoSoValue data, the overall crypto market sector remains in a consolidation phase. Bitcoin (BTC) rose by 0.33%, rebounding above 77,000 US dollars after falling below 75,000 US dollars over the weekend; Ethereum (ETH) fell by 0.94%, remaining near 2,100 US dollars. In addition, the RWA sector performed strongly, rising 1.92% in 24 hours, with Ondo Finance (ONDO) up 3.58% and Keeta (KTA) up 7.83% within this sector.
Other notable sectors include: the DeFi sector, up 0.15% in 24 hours, with Genius (GENIUS) surging 10.78% due to a combination of factors such as being listed for spot trading on a certain exchange, and Hyperliquid (HYPE) rising 1.73%, breaking through 64 US dollars during trading hours and continuing to set new records; the CeFi sector increased by 0.03%, with Aster (ASTER) up 3.36%.
In other sectors, the Layer1 sector fell by 0.08%, but Zcash (ZEC) rose 2.33%; the PayFi sector declined by 0.54%, with Monero (XMR) rallying 2.75% during trading session; the Meme sector declined by 1.09%, while Banana For Scale (BANANA) rose against the trend by 6.62%; the Layer2 sector dropped by 2.08%, but Stacks (STX) remained relatively strong, up 0.28%; the NFT sector fell 4.18%, with Audiera (BEAT) dropping 13.04% within the sector.
Indices reflecting the historical performance of the sectors show that the ssiCeFi index rose by 0.04%, while the ssiAI and ssiDePIN indices fell by 9.29% and 6.36%, respectively.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.

CoreWeave (CRWV.US) Faces Key Earnings Test: AI Cloud Debt Concerns Intensify as "Burning Cash for Growth" Model Faces Scrutiny
CoreWeave will release its third-quarter financial report. Whether it can demonstrate that its rapid revenue growth is sufficient to cover the rising financing costs and construction expenditures will directly determine the direction of market confidence.

